Acute treatment of myocardial infarction in Canada 1999-2002
Jackevicius CA, Alter D, Cox J, Daly P, Goodman S, Filate W, Newman A, Tu JV; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2005; 21(2):145-52.
Publications
Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research
Lee DS, Donovan L, Austin PC, Gong Y, Liu PP, Rouleau JL, Tu JV. Med Care. 2005; 43(2):182-8.
Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors
Battistella M, Mamdani MM, Juurlink DN, Rabeneck L, Laupacis A. Arch Intern Med. 2005; 165(2):189-92.
Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure
Tu K, Mamdani M, Kopp A, Lee D. Am J Cardiol. 2005; 95(2):283-6.
Statin use and survival outcomes in elderly patients with heart failure
Ray JG, Gong Y, Sykora K, Tu JV. Arch Intern Med. 2005; 165(1):62-7.
Routine utilization of glycoprotein IIb/IIIa inhibitor therapy is associated with improved in-hospital outcome after percutaneous coronary intervention: insights from a large prospective single-centre registry
Jackevicius CA, Pinto R, Daly P, Mackie K, Dzavik V. Can J Cardiol. 2005; 21(1):27-32.
A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin
Juurlink DN, Mamdani MM, Kopp A, Herrmann N, Laupacis A. Br J Clin Pharmacol. 2005; 59(1):102-7. Epub 2004 Dec 16.
Impact of the choice of benchmark on the conclusions of hospital report cards
Austin PC, Alter DA, Anderson GM, Tu JV. Am Heart J. 2004; 148(6):1041-6.
Effect of age on the use of evidence-based therapies for acute myocardial infarction
Tran CT, Laupacis A, Mamdani MM, Tu JV. Am Heart J. 2004; 148(5):834-41.
Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial infarction mortality
Austin PC, Tu JV. J Clin Epidemiol. 2004; 57(11):1138-46.